glp-1 leptin and GLP-1: The Next (old) Frontier in Obesity Treatment? Effects of central GLP‐1 on
Description
In the search for this prophesised molecule, Dr Joel Habener and his team at Massachusetts General Hospital decided in the late 1970s to study glucagon, another hormone produced by the pancreas that has an opposite action to insulin and increases blood glucose levels
This is particularly important for blood glucose-lowering medications, insulin, or sulfonylureas, because the risk of low blood sugar may increase
Extracellular vesicle-contained eNAMPT delays aging and extends lifespan in mice
Is Saxenda cheaper than Ozempic
Sato, S
